Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001032034 | SCV001195341 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2F | 2019-07-16 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 2 to 3 of the SGCD gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 3 of the SGCD gene. This is expected to result in an absent or disrupted protein product. This variant has been reported in at least one individual affected with muscular dystrophy and progressive muscle weakness (PMID: 26077850, 26633542) For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in SGCD are known to be pathogenic (PMID: 8841194, 10735275, 10838250). |